In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Increased HEY1 Expression Contributes to Glioma Progression and Promotes Glioma Cell Growth

    Final Number:
    1594

    Authors:
    Kiran Kumar Velpula PhD; Maheedhara R. Guda PhD; Sarah E. Martin MD; Andrew J. Tsung MD

    Study Design:
    Laboratory Investigation

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2016 Annual Meeting

    Introduction: Glioblastoma multiforme (GBM) is a highly aggressive brain tumor characterized by increased necrosis and intense resistance to therapy. Although, little is known about the molecular mechanisms that underlie glioblastoma formation, a number of signal transduction routes, such as the Notch, EGFR and p53 pathways, seem to play an important role in the formation/maintenance of GBM.

    Methods: Notch signaling is aberrantly activated in GBM and orchestrates the malignant traits of GBM, but current knowledge regarding the downstream players of Notch in GBM remains limited. Recently we have identified that Notch effector HEY1 is highly upregulated in hGBM (human) surgical biopsies and its overexpression appears to be correlative with high-grade glioma. Our immunoblot experiments revealed that HEY1 expression significantly correlated with O6-alkylguanine DNA alkyltransferase (MGMT) levels in hGBM specimens.

    Results: The inhibition of HEY1 reduced invasive, migratory and proliferative abilities of GBM cells, in vitro. Furthermore, our experiments with TF-TF; TF-DNA arrays conducted using recombinant HEY1 showed its interaction with multiple transcription factors emphasizing its importance in GBM, highlighting HEY1 as a potential therapeutic target that can be evaluated in GBM.

    Conclusions: These data obtained help us on delineating the role of HEY1 in regulating GBM tumor growth and progression.

    Patient Care: Implication of larger array of potential targets are to be studied for therapeutic purpose to improve our current understanding of the mechanistic insight required to translate these therapies into clinical treatment paradigms.

    Learning Objectives: Implication of larger array of potential targets are to be studied for therapeutic purpose to improve our current understanding of the mechanistic insight required to translate these therapies into clinical treatment paradigms.

    References: Gaetani P, Hulleman E, Levi D, et al., Expression of the transcription factor HEY1 in glioblastoma: a preliminary clinical study.Tumori. 2010 Jan-Feb;96(1):97-102. Hulleman E, Quarto M, Vernell R, et al., A role for the transcription factor HEY1 in glioblastoma. J Cell Mol Med. 2009 Jan;13(1):136-46.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy